Nektar Therapeutics
NKTR
$1.32
Share price
0.00%
Change (1 day)
76.00%
Change (1 year)
Categories
P/S ratio for Nektar Therapeutics (NKTR)
P/S ratio as of April 2024 (TTM): 2.69
According to Nektar Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.68942. At the end of 2023 the company had a P/S ratio of 1.20.
P/S ratio history for Nektar Therapeutics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.20 | -74.08% |
| 2022 | 4.61 | -81.14% |
| 2021 | 24.5 | 22.68% |
| 2020 | 19.9 | -40% |
| 2019 | 33.2 | 595.41% |
| 2018 | 4.78 | -84.36% |
| 2017 | 30.6 | 169.61% |
| 2016 | 11.3 | 14.76% |
| 2015 | 9.88 | -2.52% |
| 2014 | 10.1 | 14.13% |
| 2013 | 8.88 | -15.6% |
| 2012 | 10.5 | 17.45% |
| 2011 | 8.96 | 17.28% |
| 2010 | 7.64 | -36.81% |
| 2009 | 12.1 | 112.06% |
| 2008 | 5.70 | 151.25% |
| 2007 | 2.27 | -64.43% |
| 2006 | 6.38 | -44.22% |
| 2005 | 11.4 | -23.68% |
| 2004 | 15.0 | 108.11% |
| 2003 | 7.20 | 52.09% |
| 2002 | 4.73 | -64.13% |
| 2001 | 13.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.79 | 40.77% | 🇺🇸 USA |
 Pfizer PFE | 2.46 | -8.58% | 🇺🇸 USA |
 Amgen AMGN | 5.14 | 91.01% | 🇺🇸 USA |
 Baxter BAX | 1.37 | -49.16% | 🇺🇸 USA |
 Merck MRK | 5.53 | 105.56% | 🇺🇸 USA |
 AstraZeneca AZN | 4.90 | 82.01% | 🇬🇧 UK |
 Richardson Electronics RELL | 0.6864 | -74.48% | 🇺🇸 USA |
 Alkermes ALKS | 2.51 | -6.66% | 🇮🇪 Ireland |